Effect of Heat-Treated Lactiplantibacillus plantarum nF1 on the Immune System Including Natural Killer Cell Activity: A Randomized, Placebo-Controlled, Double-Blind Study.
Geun-Hye HongSo-Young LeeIn Ah KimJangmi SukChaemin BaegJi Yeon KimSehee LeeKyeong Jin KimKi Tae KimMin Gee KimKun-Young ParkPublished in: Nutrients (2024)
Heat-treated Lactiplantibacillus plantarum nF1 (HT-nF1) increases immune cell activation and the production of various immunomodulators (e.g., interleukin (IL)-12) as well as immunoglobulin (Ig) G, which plays an important role in humoral immunity, and IgA, which activates mucosal immunity. To determine the effect of HT-nF1 intake on improving immune function, a randomized, double-blind, placebo-controlled study was conducted on 100 subjects with normal white blood cell counts. The HT-nF1 group was administered capsules containing 5 × 10 11 cells of HT-nF1 once a day for 8 weeks. After 8 weeks of HT-nF1 intake, significant changes in IL-12 were observed in the HT-nF1 group ( p = 0.045). In particular, the change in natural killer (NK) cell activity significantly increased in subjects with low secretory (s) IgA (≤49.61 μg/mL) and low NK activity (E:T = 10:1) (≤3.59%). These results suggest that HT-nF1 has no safety issues and improves the innate immune function by regulating T helper (Th)1-related immune factors. Therefore, we confirmed that HT-nF1 not only has a positive effect on regulating the body's immunity, but it is also a safe material for the human body, which confirms its potential as a functional health food ingredient.
Keyphrases
- signaling pathway
- lps induced
- pi k akt
- nuclear factor
- oxidative stress
- induced apoptosis
- inflammatory response
- clinical trial
- randomized controlled trial
- nk cells
- public health
- endothelial cells
- toll like receptor
- squamous cell carcinoma
- cell proliferation
- physical activity
- stem cells
- cell cycle arrest
- single cell
- innate immune
- radiation therapy
- bone marrow
- regulatory t cells
- cell death
- heat stress
- weight loss
- mesenchymal stem cells
- drug induced
- rectal cancer
- health promotion